Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$548.35 - $738.84 $52,093 - $70,189
-95 Reduced 69.34%
42 $25,000
Q1 2022

May 10, 2022

SELL
$595.12 - $698.43 $226,145 - $265,403
-380 Reduced 73.5%
137 $96,000
Q4 2021

Feb 01, 2022

SELL
$543.48 - $670.97 $64,130 - $79,174
-118 Reduced 18.58%
517 $326,000
Q3 2021

Nov 10, 2021

SELL
$574.03 - $680.96 $22,961 - $27,238
-40 Reduced 5.93%
635 $384,000
Q2 2021

Aug 12, 2021

SELL
$472.8 - $558.54 $622,677 - $735,597
-1,317 Reduced 66.11%
675 $377,000
Q1 2021

May 14, 2021

SELL
$446.73 - $548.2 $163,503 - $200,641
-366 Reduced 15.52%
1,992 $942,000
Q4 2020

Feb 08, 2021

SELL
$478.3 - $607.98 $410,859 - $522,254
-859 Reduced 26.7%
2,358 $1.14 Million
Q3 2020

Nov 12, 2020

SELL
$544.75 - $658.21 $818,214 - $988,631
-1,502 Reduced 31.83%
3,217 $1.8 Million
Q2 2020

Aug 11, 2020

BUY
$493.32 - $643.92 $997,493 - $1.3 Million
2,022 Added 74.97%
4,719 $2.94 Million
Q1 2020

May 08, 2020

SELL
$336.18 - $494.43 $258,858 - $380,711
-770 Reduced 22.21%
2,697 $1.32 Million
Q4 2019

Feb 12, 2020

SELL
$274.13 - $376.51 $40,297 - $55,346
-147 Reduced 4.07%
3,467 $1.3 Million
Q3 2019

Nov 12, 2019

SELL
$273.46 - $318.39 $253,223 - $294,829
-926 Reduced 20.4%
3,614 $1 Million
Q2 2019

Jul 30, 2019

BUY
$299.6 - $414.82 $1.36 Million - $1.88 Million
4,540 New
4,540 $1.42 Million
Q1 2019

May 13, 2019

SELL
$372.08 - $439.57 $445,379 - $526,165
-1,197 Closed
0 $0
Q4 2018

Feb 08, 2019

BUY
$335.82 - $403.04 $82,275 - $98,744
245 Added 25.74%
1,197 $447,000
Q3 2018

Nov 09, 2018

SELL
$351.14 - $408.51 $89.7 Million - $104 Million
-255,455 Reduced 99.63%
952 $384,000
Q3 2018

Nov 07, 2018

BUY
$351.14 - $408.51 $89.7 Million - $104 Million
255,465 Added 27119.43%
256,407 $11.6 Million
Q2 2018

Aug 13, 2018

BUY
$284.6 - $344.99 $234,795 - $284,616
825 Added 705.13%
942 $326,000
Q1 2018

May 04, 2018

BUY
$315.82 - $393.78 $36,950 - $46,072
117 New
117 $35,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Agf Investments LLC Portfolio

Follow Agf Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Agf Investments LLC with notifications on news.